Pay Offline via Postal Bank Draft or Bank Wire Transfer (SGD 2020):
Pay Offline
SUBMISSIONS CLOSED/GUIDELINES
Submission dates
Date
|
Description
|
Feb 15
|
Submission begins
|
Apr 30 May 15 My 25
|
Full paper submission deadline at 23:59 GMT
|
May 15 May 25
|
Tutorial, highlights, technology, poster abstract submission deadline at 23:59 GMT
|
Click here for important notification dates.
Submission procedure
We invite you to participate in the following sessions:
All submissions to InCoB 2009 is through the EasyChair conference system.
The submission process requires registration to create an EasyChair account prior to submission.
Submitted full Papers are automatically considered for publication
in special supplements of BMC Genomics
(Impact Factor 4.18) and Bioinformation.
EasyChair submission page: http://www.easychair.org/conferences/?conf=incob2009
Login for programme committee: http://www.easychair.org/conferences/?conf=incob2009
Posters
We solicit high-quality research posters in any aspect of bioinformatics
and computational biology conveying a scientific result. At least one
author of each selected poster must register for InCoB2009. Furthermore,
a single registration can cover only only oral presentation and one
poster presentation or two poster presentations.
You must submit within one document (PDF format), a title and two versions of your poster abstract: a 50-word abstract
that will be printed in the conference program and a one-page abstract (~250 words) that will be posted on the conference
web site.
Please refer here for list of accepted posters.
Tutorials
InCoB2009 will feature a limited number of half-day tutorials on 7-8 Sept.,
on either well-established or new and emerging, cutting-edge topics,
relevant to bioinformatics. Lecture materials and instruction notes are
required from the presenter, who will be a provided a free InCoB2009.
registration.
You must submit within one document (PDF format), two versions of your tutorial abstract: a 50-word abstract
that will be printed in the conference program and a one-page abstract (~250 words) that will be posted on the conference
web site.
Highlights track
We invite abstracts on full papers that have been published or accepted
for publication (please provide us email acceptance or online version)
after Septmeber 1, 2008. A group of experts will select abstracts to be
presented at the meeting, considering the impact of the work on the
field, the likelihood that the study would be of interest to the
InCoB audience and the relevance of the research to bioinformatics
and application to molecular and medical sciences. Presenters must
register for InCoB2009.
Technology track
The Technology Track provides an opportunity for showcasing
- bioinformatics resources
- software or hardware developments relevant to the community
Databases, web sevices, software and recently available hardware tools
are some suggestions for this track.
Presenters must register for InCoB2009.
Full papers
A single PDF file with all tables and figures is to be submitted to EasyChair for review.
Full papers submitted to InCoB 2009 should be divided into the following sections:
Title page
This should include: manuscript title, which should give an accurate, clear and concise description of the reported work, avoiding abbreviations; and the full names, institutional addresses, and e-mail addresses for all authors. The corresponding author should also be indicated.
Abstract
The abstract of the manuscript should not exceed 350 words and must be structured into separate sections: Background, the context and purpose of the study; Results, the main findings; Conclusions, brief summary and potential implications. Please minimize the use of abbreviations and do not cite references in the abstract.
Background
The background section should be written from the standpoint of researchers without specialist knowledge in that area and must clearly state - and, if helpful, illustrate - the background to the research and its aims. The section should end with a very brief statement of what is being reported in the article.
Results and Discussion
The Results and Discussion may be combined into a single section or presented separately. They may also be divided into subsections with short, informative headings.
Conclusions
This should state clearly the main conclusions of the research and give a clear explanation of their importance and relevance. Summary illustrations may be included.
Methods
This should be divided into subsections if several methods are described.
List of abbreviations
If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided, which should precede the authors' contributions and acknowledgements.
Authors' contributions
In order to give appropriate credit to each author of a paper, the individual contributions of authors to the manuscript should be specified in this section.
An "author" is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; and 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship.
All contributors who do not meet the criteria for authorship should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support.
Authors' information
You may choose to use this section to include any relevant information about the author(s) that may aid the reader’s interpretation of the article, and understand the standpoint of the author(s). This may include details about the authors' qualifications, current positions they hold at institutions or societies, or any other relevant background information. Please refer to authors using their initials. Note this section should not be used to describe any competing interests.
Acknowledgements
Please acknowledge anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Please also include their source(s) of funding. Please also acknowledge anyone who contributed materials essential for the study.
Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements.
Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section. Authors must describe the role of the funding body, if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.
References
All references must be numbered consecutively, in square brackets, in the order in which they are cited in the text, followed by any in tables or legends. Reference citations should not appear in titles or headings. Each reference must have an individual reference number. Please avoid excessive referencing. If automatic numbering systems are used, the reference numbers must be finalized and the bibliography must be fully formatted before submission.
Only articles and abstracts that have been published or are in press, or are available through public e-print/preprint servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in the reference list, but may be included in the text. Notes/footnotes are not allowed. Obtaining permission to quote personal communications and unpublished data from the cited author(s) is the responsibility of the author. Journal abbreviations follow Index Medicus/MEDLINE. Citations in the reference list should contain all named authors, regardless of how many there are.
Figures
Figures should be placed sequentially at the end of the manuscript file, with one figure per page.
Figure legends
The legends should be included in the main manuscript text file immediately following the references, rather than being a part of the figure file. For each figure, the following information should be provided: Figure number (in sequence, using Arabic numerals - i.e. Figure 1, 2, 3 etc); short title of figure (maximum 15 words); detailed legend, up to 300 words.
Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures or tables that have previously been published elsewhere.
Tables and captions
Tables should be in the main manuscript text, with one table per page numbered in sequence using Arabic numerals (i.e. Table 1, 2, 3 etc.). Tables should also have a title that summarizes the whole table, maximum 15 words. Detailed legends may then follow, but should be concise.
Additional files
Larger datasets can be uploaded separately as additional files. Additional files will not be displayed in the final, published form of the article, but a link will be provided to the files as supplied by the author.
A compress .zip file of the additional materials can be uploaded to EasyChair.
Accepted Articles
For submissions accepted to the BMC Genomics special issue on InCoB 2009, detailed formatting
instructions,
under "Preparing main manuscript text", are available at
http://www.biomedcentral.com/bmcgenomics/ifora/.
For submissions accepted to the Bioinformation special issue on InCoB 2009, detailed formatting instructions,
under "Author Guidelines", are available at
http://www.bioinformation.net/journal/instructions.htm.